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Background: The molecular machinery controlling exocytosis of the three secretable granules types in platelets is not fully
elucidated.
Results: ATP secretion, aggregation, and thrombus stability are defective in Stx8/mouse platelets.
Conclusion: STX8 is involved in platelet dense granule secretion, and the STX8-mediated pathway contributes to thrombus
stabilization.
Significance: Identification of the novel functional SNARESTX8 suggests alternativemechanisms of granule secretion exist in platelets.
Platelet secretion not only drives thrombosis and hemostasis,
but also mediates a variety of other physiological and patholog-
ical processes. The ubiquitous SNAREmachinery and a number
of accessory proteins have been implicated in regulating secre-
tion in platelet. Although several platelet SNAREs have been
identified, furthermembers of the SNARE familymaybeneeded
to fine-tune platelet secretion. In this study we identified
expression of the t-SNARE syntaxin 8 (STX8) (Qc SNARE) in
mouse and human platelets. In mouse studies, whereas STX8
was not essential for -granule or lysosome secretion, Stx8/
platelets showed a significant defect in dense granule secretion
in response to thrombin andCRP. This wasmost pronounced at
intermediate concentrations of agonists. They also showed an
aggregation defect that could be rescued with exogenous ADP
and increased embolization in Stx8/ mice in vivo consistent
with an important autocrine and paracrine role for ADP in
aggregation and thrombus stabilization. STX8 therefore specif-
ically contributes to dense granule secretion and represents
another member of a growing family of genes that play distinct
roles in regulating granule release from platelets and thus plate-
let function in thrombosis and hemostasis.
Platelet secretory granules, -granules, dense granules, and
lysosomes contain a plethora of active substances that regulate
thrombosis and hemostasis, and increasingly found to contrib-
ute to other physiological and pathological processes, such as
inflammation (1), angiogenesis (2), and malignancy (3).
Our understanding of platelet secretion has developed tremen-
dously since the first description of the ubiquitous SNARE secre-
torymachinery inplateletsbyLemons etal. (4).Wenowknowthat
regulatory proteins including small GTPases (5–7), MUNC pro-
teins (8, 9), andcalciumsensors (10, 11) contribute to regulationof
platelet secretion alongside the “core” SNARE complex.
The functional core SNARE complex invariably consists of 4
SNARE domains: three t-SNARE domains (residing on the tar-
get membrane) and a v-SNARE on the vesicle form a tight het-
erotetrameric complex that drives membrane fusion (12). The
majority of mammalian SNAREs, including all syntaxins and
SNAP23 homologues, are classified as t-SNAREs, whereas
VAMPs function as v-SNAREs. Although SNAREs are func-
tionally classified as v-SNAREs or t-SNAREs, they can also be
structurally distinguished as Qabc or R types according to the
amino acid residue (glutamine and arginine) located in the cen-
ter of the functional complex (13). Both the functional organi-
zation and the structure of the central SNARE complex are
remarkably conserved between cells, and even species (14).
The currently accepted platelet secretion machinery is the
complex of STX112 (a Qa SNARE), SNAP23 (Qbc), and
VAMP8 (an R SNARE); however, in light of the level of tempo-
ral and spatial regulation required in platelet secretion, the “one
size fits all” model does not seem to be plausible. In addition,
even loss of STX11 (in FHL4 patients) (15) or knock-out of
VAMP8 coupled with tetanus neurotoxin (TnT-LC) treatment
(16) does not lead to full ablation of secretion, suggesting
ranked redundancy and compensation mechanisms (16). The
evidence supporting SNAP23 is even more indirect and reliant
upon treatment of SLO-permeabilized platelets with functional
blocking antibodies and the correlative evidence of phosphor-
ylation of SNAP23 occurring at a similar rate to secretion
(17–20).
There are numerous examples of SNARE redundancy and
specialization in secretory cells, for example, neutrophils (21).
However, in those cells approaches such as protein overexpres-
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sion or targeted introduction of specific antibodies by elec-
tropermeabilization (21) allow for easier characterization of
SNARE function in secretion. Characterization of similar pro-
cesses in platelets remains more challenging.
We hypothesized that other SNARE proteinsmay help “fine-
tune” secretion alongside the VAMP8-STX11-SNAP23 com-
plex. There is substantial expression evidence that additional
SNAREs are present in platelets, but currently there are several
of these that have not been investigated (22–25).We decided to
prioritize characterization of a syntaxin STX8, an abundant Qc
SNARE, which could partially substitute for SNAP23 (which in
the current model contributes both Qb and Qc domains) in
platelet SNARE complexes (26).
Here we report that syntaxin 8 (STX8) (Qc) is expressed in
mouse and human platelets, and localizes to the membrane
fraction of platelets.We have also found that it forms a complex
with STX11 in human platelets, which unlike the activation-de-
pendent STX11-SNAP23-VAMP8 complex, is present in rest-
ing platelets.We also show a novel role for STX8 in dense gran-
ule secretion in mouse platelets in response to intermediate
agonist stimulation in vitro, and impairment of aggregation sec-
ondary to this defect.Most importantly, however, we show that
the embolization rate from thrombi in vivo was significantly
increased in the absence of STX8, whereas the total size of the
thrombus and rate of adhesion as measured by traditional
methods remained unchanged. This suggested that the rela-
tively subtle deficit in dense granule secretion can result in a
substantial physiological defect downstream.
This study is the first to suggest a role for STX8 in platelet
secretion and function, which opens up the possibility of other
SNAREs playing secondary roles to the “main” SNARE com-
plex, as previously reported in the case of VAMP homologues
(16). Our results are consistent with previous suggestions of
differential secretion of granule types in platelets. In addition,
we show that apparently minor defects in dense granule secre-
tion observed in vitro can still have significant effects in vivo.
EXPERIMENTAL PROCEDURES
Human and Mouse Platelet Preparation—For human plate-
let experiments, blood was taken from aspirin-free healthy vol-
unteers who gave full informed consent. For mouse platelet
experiments, Stx8/ embryos were supplied by theWellcome
Trust Sanger Institute (Cambridge, UK), and rederived at the
University of Bristol animal facility.Vti1b/mice were gener-
ated as described previously (27). Mice, minimum 8 weeks of
age, of mixed sex were used for all experiments, and compared
with wild-type littermates or sex- and age-matched C57Bl6/j
wild-type controls. Blood was drawn into 4% trisodium citrate
(1:9) by posterior vena cava puncture of mice humanely eutha-
nized by exposure to rising CO2 gas concentrations as per
Schedule 1 of ASPA, 1986. Complete blood counts were con-
ducted using a Pentra ES60 hematology analyzer (HoribaMed-
ical, Northampton, UK) prior to platelet preparation and
counts were adjusted for anticoagulant volume. Washed plate-
lets were prepared as described in Goggs et al. (28), and rested
for 60 min at 30 °C in the presence of 10 M indomethacin and
0.02 units/ml of apyrase prior to stimulation. Experiments were
performed in the presence of indomethacin as a standard to
minimize signaling contributions from receptors other than the
primary receptor being activated.
Protein Electrophoresis andWestern Blotting—Washed platelet
lysates were separated on SDS-PAGE, and PVDF membranes
were probed with specific primary antibodies: VAMP8,
SNAP23, STX11, VTI1B (all rabbit IgG, Synaptic Systems
GmBH,Göttingen, Germany), STX8 (sheep IgG, R&DSystems,
Abingdon, UK), GAPDH (mouse IgG, Santa Cruz Biotechnol-
ogy, Heidelberg, Germany), -tubulin (mouse IgG), and FcR
(rabbit IgG, both Abcam, Cambridge, UK). Membranes were
washed in excess TBS-T and incubated with appropriate HRP-
conjugated secondary antibodies (mouse and rabbit, GE
Healthcare Life Sciences; sheep, Jackson ImmunoResearch,
Stratech, Newmarket, UK). Protein levels were quantified using
ImageJ analysis software and compared using ANOVA.
Digitonin Fractionation of Human Platelets—Human plate-
lets were incubated with an equal volume of 0.1% digitonin in
phosphate-buffered saline (PBS) supplemented with protease
inhibitormixtures for 120 s on icewith intermittent agitation.The
sampleswerecentrifugedat1,800g for10minat4 °Ctoseparate
the soluble (cytosolic) fraction from the digitonin-insolublemem-
brane-bound fraction. The supernatants were extracted with 4
SDS sample buffer. The remaining insoluble pellet was washed
twicewith ice-cold PBS and solubilizedwith 0.1%TritonX-100 in
PBS for 5 min and centrifuged as before. The supernatant was
extracted as before andmembrane and cytosol fractionswere sep-
arated using SDS-PAGE, and localization was confirmed with
Western blotting relative to FcR (membrane fraction marker)
and GAPDH (cytosolic fractionmarker).
Co-immunoprecipitation—Double-washed human platelets,
resting or activated with 1 unit/ml of thrombin, were lysed in
equal volumes of 2 ice-cold lysis buffer (40 mM Tris-HCl, pH
7.5, 150 mMNaCl, 2 mM EDTA, 2 mM EGTA, 2% Triton X-100,
1% sodiumdeoxycholate, protease andphosphatase inhibitors).
Lysates were precleared by centrifugation at 4 °C for 15 min at
1800 g and incubated with 2 g of relevant primary antibody
or isotype-nonspecific IgG overnight at 4 °C. Immune com-
plexes were precipitated with Protein A or G beads blocked
with 2% BSA protein eluted by boiling for 5 min at 95 °C. The
eluates were then separated by electrophoresis as described.
Dense Granule Secretion and Platelet Aggregation—Aggrega-
tion and ATP secretion were measured under stirring (1000
RPM) conditions using Born lumi-aggregometer (560-VS,
Chrono-Log, Havertown, PA) as previously described (28).
Aggregation was expressed as a decrease in optical density of
the sample. ATP secretion was normalized to WT control on
each experimental day as appropriate.
Flow Cytometry—Expression of surface glycoproteins was
measured by incubating platelets (2  107/ml) with FITC-la-
beled antibodies for CD41, GPVI, and GPIb or isotype-non-
specific IgG for 10 min (all Emfret, Germany). For surface
expression of P-selectin and integrin IIb3 activation assay,
platelets were stimulated with agonists under non-stirring con-
ditions and incubated with FITC-CD62P and PE-JON/A anti-
bodies (both Emfret) for 10 min. Platelets were analyzed using
FACSCalibur and proprietary software (Cell Quest, BD Biosci-
ence). Platelets were identified by forward and side-scatter
properties. For dual color experiments, compensation controls
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were produced using FITC- and PE-stained beads (Calibrite
Beads, BD Bioscience) and applied to all fluorescence intensity
values. 20,000 platelet-gate events were collected per experiment.
Lysosome Secretion—-Hexosaminidase release was mea-
sured as described previously (29). Mouse platelets were stim-
ulated with increasing concentrations of thrombin at 37 °C for
10 min under non-stirring conditions and the supernatant
added to 20l of 0.1 M 4-nitrophenyl n-acetyl--D-glucosamin-
ide (Sigma) substrate in citrate-phosphate buffer (0.2 M
Na2HPO4, 0.1 M citric acid, pH 4.2) in a 96-well plate. Total
controls for -hexosaminidase activity were obtained by
repeated snap-freeze/thaw of the same volume of non-stimu-
lated platelets. The reaction was quenched with NaOH after a
1-h incubation at 37 °C and absorbance was read at 405 nm
(Opsys MR, Dynex Technologies, Worthing, UK). Secreted
-hexosaminidase was expressed as percentage of TOTAL.
[3H]5-HT Loading Assay—Mouse platelet-rich plasma was
incubated with 3H-labeled 5-HT (PerkinElmer Life Sciences)
(0.5 Ci/ml of platelet-rich plasma) at 37 °C for 1 h. The total
loading values were obtained by lysis of equal volume of
Stx8/ and WT unstimulated platelets in 6% glutaraldehyde
with 0.1% Triton X-100, which were then transferred to scintil-
lation fluid in 3-ml vials and CPM (counts per minute) were
measured using a scintillation counter.
In Vitro Thrombus Formation in Whole Blood—Thrombus
formation in whole blood was measured as previously described
(30). Mouse blood anticoagulated with sodium citrate was col-
lected as described above, with additional heparin (2 units/ml),
and D-phenylalanyl-L-propyl-L-arginine chloromethyl ketone (40
M) was labeled with DiOC6 (1M) and passed over immobilized
collagen (50g/ml) or fibrinogen (100g/ml) (all Sigma) through
a parallel plate perfusion chamber at a shear rate of 1000 s1 for 3
min. Fluorescence images were captured at 4 frames/s with a
BX51WImicroscope (OlympusUK, Southend-on-Sea, UK) using
a 40 water dipping objective, a Rolera-XR digital camera, and
QCapture software (QImaging, Surrey, BC, Canada). Coverslips
were then washed with HEPES-Tyrode’s buffer to remove non-
adherent cells and 30 random images were collected for each
experiment. Surface coverage during flow and post washing was
analyzed using ImageJ.
In Vivo Thrombus Formation—In vivo thrombus formation
assays were performed as previously described (30). Mice were
anesthetized with an intraperitoneal injection of 100 mg/kg of
ketamine and 10 mg/kg of xylazine. Vascular access was
obtained by catheterization of the left external jugular vein.
Platelets were labeled by intravenous administration of 100
mg/kg of Dylight 488-conjugated anti-GPIb antibody. Right
carotid arteries were exposed using aluminum foil and 2 
1-mm 15% ferric chloride-soaked filter paper placed on the
arterial adventitia for 3 min. Time-lapse microscopy of the
injury site for 20 min was performed and images processed
using ImageJ. Background florescence values were measured
upstream of the injury site were subtracted from thrombus-
specific fluorescence and the data expressed as integrated den-
sity values. The number of embolization events was counted by
reviewing the videos of each experiment 3 times (blinded).
Tail Bleeding Assay—Mice were anesthetized as described
above. Using a scalpel, 5 mm of tail was resected from the tip,
and the tail was immersed in saline (37 °C). Times from incision
to cessation of bleeding were recorded.
ElectronMicroscopy—Mouse platelet samples were prepared
for TEM at the University of BristolWolfson Bioimaging Facil-
ity, as previously described (31).
Statistics—Data are presented as mean S.E. and statistical
significance was determined by two-way ANOVAwith Bonfer-
roni post-test, performed using Prism 5.0 (GraphPad Software,
San Diego, CA). p 0.05 was considered significant.
RESULTS
Identification of a Novel SNARE STX8 in Platelets—We
wanted to confirm that STX8 is expressed in both mouse and
human platelets. Western blotting revealed that it is present (Fig.
1a), alongside theotherpreviously reportedSNAREsSNAP23and
STX11.This is the first report of expressionof STX8at theprotein
level in platelets. To confirm its membrane localization we per-
formed digitonin fractionation and found that it localized to the
same digitonin-insoluble fraction as FcR and another SNARE,
STX11, which confirmedmembrane association of these proteins
(Fig. 1B). Using a co-immunoprecipitation approach, we found
that STX8 formed a complex with STX11, deletion of which is
responsible for platelet secretion defects in FHL4 patients (15), in
both resting and thrombin-activatedplatelets (Fig. 1C). That com-
FIGURE 1. Expression of SNARE STX8 in platelets, its localization and inter-
actions. A, resting human andmouse platelets were lysed in SDS sample buffer
andproteinswere separatedonSDS-PAGE.The resultingblotswereprobedwith
antibodies as shown. B, human double washed platelets were solubilized using
digitonin as described. The resulting digitonin-soluble (cytosol) and digitonin-
insoluble (membrane) fractions were separated on SDS-PAGE and blotted as
before and localization of STX8was comparedwith localization of Fc receptor 
signaling chain (FcR, membrane marker), GAPDH (cytosol marker), and STX11
(membrane-associated SNARE). C, human resting (R) and activated (A, 1 unit/ml
of thrombin)doublewashedplateletswere lysedasdescribedandproteinswere
immunoprecipitated (IP) with relevant antibodies. The resultant immune com-
plexes were denatured, separated on SDS-PAGE, and blotted as before. Rabbit
nonspecific Ig controls (same species as IP antibodies) were also included.D, the
STX8-STX11 complex identifiedwas found tobe constitutive,with no significant
changeuponactivationasquantifiedusing ImageJ (n4).Data shown (A–C) are
representative of at least 3 experiments, error bars represent S.E.
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plexwas not significantly enhanced in activated platelets (Fig. 1D).
Wehavenot foundany interactionofQbSTX8withQbcSNAP23,
consistent with the requirement of only one Qb SNARE domain
for the functional SNAREcomplex (Fig. 1C).VAMP8-STX8 inter-
action was previously reported in the PC12 cell endosomal trans-
port network (32), but we could not replicate that observation in
platelets. Thismay suggest that anotherRSNARE is present in the
complex with STX8 and STX11, consistent with the ranked
redundancyofRSNAREs inplatelets (16).The constitutive STX8-
STX11 association is in contrast with the previously reported
platelet SNARE complex, STX11-SNAP23-VAMP8, which under
our solubilization conditions (as per Karim et al. (20)) was con-
firmed to be activation dependent (Fig. 1c and data not shown).
Despite using four different STX8 antibodies in this project (Syn-
aptic Systems polyclonal rabbit anti-STX8 (number 110-083),
SantaCruz Biotechnologymonoclonalmouse anti-STX8 (48) (sc-
136092), in-house rabbit polyclonal anti-STX8 antibody devel-
oped at the University of Bielefeld, and R&D Systems sheep poly-
clonal anti-STX8 antibody (AF5448)) we did not manage to
immunoprecipitate STX8 in this project to provide the reciprocal
control (data not shown).
Analysis of Stx8/Mouse Platelets—Association with STX11
identified in human platelets suggested a possibility for functional
importance of STX8. Therefore we obtained a global mouse
knock-out model to investigate the role of STX8 in platelets.
Stx8/ mice have comparable erythrocyte, leukocyte, and
platelet counts to wild-type, and platelets from thesemice were
normal in size (Table 1). Electron microscopy of resting
Stx8/ platelets confirmed normal platelet morphology, with
both dense and-granules present (Fig. 2a). Surface expression
FIGURE 2. Initial characterization of Stx8/ platelets. A, resting platelets were prepared for TEM imaging, and images were acquired using Tecnai-12
electron microscope at4300 magnification. Arrows denote  granules, arrowheads denote dense granules (scale bar: 1 m). Images are representative of 3
independent observations.B, the levels of glycoprotein expressionweremeasuredusing FACS and comparedwith expression levels ofWTplatelets. Therewas
no significant difference between the genotypes (n 5, p 0.05, two-way ANOVA). Error bars represent S.E.
FIGURE 3. Quantification of granule secretion in Stx8/ platelets. All
concentration-response data were analyzed by appropriate curve fitting
in GraphPad Prism. A, mouse platelets were stimulated in the aggregom-
eter as described. Dense granule secretion wasmeasured as an increase in
luminescence relative to ATP standard for each stimulation. Data were
normalized to maximum ATP secretion of WT platelets on the day of
experiment. There was a significant increase in [thrombin] EC50 in Stx8
/
(95% CI of EC50: 0.085 to 0.11 units/ml) compared with WT platelets (95%
CI of EC50: 0.068 to 0.086 units/ml) (n  5, variable slope sigmoidal dose-
response curve, p 0.0248). Stx8/ andWT secretion in response to 0.06
units/ml was, respectively, 1.742  0.618 and 10.379  3.767% of the
maximumWT secretion on the day (n 4, p 0.05, ns), and in response to
0.075 units/ml of thrombin: 6.927  5.970 and 38.933  20.969% of the
maximum WT secretion, p  0.0339). B, the total 5-HT content was mea-
sured using 3H-labeled 5-HT as described. There was no significant differ-
ence in 5-HT content between genotypes (n  3). C, -granule secretion
was measured by FACS. Median fluorescent intensity (MFI) of FITC-CD62P
was quantified in response to increasing concentrations of thrombin.
MFI was normalized to the maximum MFI of WT platelets on the day of
experiment (n  4). D, lysosome secretion was measured by -hexo-
saminidase enzyme activity in supernatants following stimulation with
increasing concentrations of thrombin. Absorbance at 405 nm was meas-
ured, and values were expressed as percentage of TOTAL control for each
subject (n 6). There was no difference in [thrombin] EC50 between gen-
otypes in -granule or lysosome secretion (p  0.05, variable slope sig-
moidal dose-response curve). Error bars represent S.E.
TABLE 1
Hematology parameters of Stx8/mice
Hematology parameters were measured in whole anticoagulated blood (adjusting
for the volume of anticoagulant). There was no difference in platelet count, mean
platelet volume (MPV), red blood cell count (RBC), or white blood cell counts
(WBC) between the genotypes (ANOVA, p 0.05).
WT Stx8/
Mean S.E. n Mean S.E. n p value
Platelet count (103/ml) 843 31 43 833 30 46 NSa
MPV (m3) 5.2 0.0 43 5.2 0.0 45 NS
WBC (103/ml) 7.6 0.5 42 6.7 0.4 45 NS
RBC (103/ml) 9.56 0.24 43 9.99 0.25 46 NS
a NS, not significant.
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of the IIb subunit of the fibrinogen receptor (GPIIb), the colla-
gen receptor GPVI, and the GPIb subunit of the von Will-
ebrand factor receptor were equivalent in Stx8/ and WT
platelets, despite GPIb levels being more variable in Stx8/
(Fig. 2B).
STX8 Is Specifically Required for Dense Granule Secretion,
and Not -Granule and Lysosome Secretion in Thrombin-acti-
vated Mouse Platelets—Assessing ATP release from dense
granules by lumi-aggregometry, we were able to show that
Stx8/ platelets released less ATP compared with the WT,
and there was a significant difference in EC50 values in
Stx8/ platelets (Fig. 3A). The defect was more pronounced
at low concentrations of agonist, and maximum secretion
was comparable, suggesting no defect in granule contents
was available for release. To further confirm that the defect
lies in secretion rather than packaging of granules, we mea-
sured total [3H]5-HT loading and found no difference
between genotypes (Fig. 3B). In contrast to dense granule
secretion, there was no difference in -granule or lysosome
secretion between genotypes.
FIGURE 4.Analysis of aggregation and ADP rescue experiments in Stx8/ platelets. A, aggregation wasmeasured using lumi-aggregometer and ampli-
tude was expressed as percentage decrease in optical density of the sample at t 180 s (n 4). The concentration-response curve for Stx8/was shifted to
the right, but [thrombin] EC50 was not significantly different (95% CI of WT EC50: 0.042 to 0.090, 95% CI of Stx8
/ EC50: 0.069 to 0.101, p 0.05). However, the
maximumaggregationamplitudewas significantly reduced in Stx8/at 0.075units/mlof thrombin (26.113.6%decrease inoptical density in Stx8/ versus
60.8  18.2% in WT, p  0.021, two-way ANOVA with Bonferroni post-test), with aggregation at 0.05 and 0.06 units/ml also consistently reduced, but not
significantly. B, integrin IIb3 activation was measured by FACS, no difference in PE-JON/A binding was observed between genotypes suggesting an alter-
nativemechanism for the observed aggregation defect. C, representative aggregation traces showing the effect of co-stimulationwith 10M exogenous ADP
response to EC50 concentrationof thrombin (i) andCRP (ii).D, aggregation in response to co-stimulationwithEC50 (0.05–0.075units/ml) thrombin and10M
ADPwas compared with EC50 thrombin alone (n 5). Stx8
/ aggregation was significantly reduced in response to thrombin alone (37.8 8.9 versus 63.4
6.1%decrease inoptical density, respectively,p0.05) andcouldbe fully rescuedwithADP (p0.05). Themaximumaggregation to1unit/ml of thrombinwas
the samebetween genotypes (data not shown). Similarly, the effect of co-stimulationwith ADP and EC50 CRP (0.3–0.5g/ml) wasmeasured (n 4). Therewas
a significant reduction in aggregation in response toEC50 CRP in Stx8
/ platelets (30.0 7.3 versus 46.3 8.6% inWT, p 0.05) that was fully rescuedwith
ADP (p 0.05). Maximum response (to 5g/ml of CRP) was the same (data not shown). E, secretion of ATPwas alsomeasured. Again, secretion in response to
EC50 concentrations of thrombin or CRP was significantly reduced (p  0.01), whereas co-stimulation with ADP could only partially rescue secretion when
thrombinwas used as primary agonist (p 0.05). In the case of co-stimulationwith CRP, ADP enhancedATP secretion to amuch greater extent in bothWT and
Stx8/ platelets (ADP enhancement of 185.75 42.55% of CRP alone, compared with 111.30 20.66% of thrombin alone). Error bars represent S.E.
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Stx8/ Platelets Have an Aggregation Defect Secondary to
Diminished Dense Granule Secretion—We also observed a
defect in platelet aggregation that followed a similar pattern to
ATP secretion (Fig. 4A). We suspected that the defect results
from insufficient ADP-mediated positive feedback at low ago-
nist concentrations. In contrast, integrin IIb3 activation was
normal when Stx8/ platelets were stimulated in 10-fold
diluted suspension (2  107/ml), suggesting that there was no
intrinsic defect in the ability of the integrin to be activated (Fig.
4b). To confirm that the aggregation defect was secondary to
dense granule secretion we repeated the aggregations in the
presence of exogenous ADP, which is normally released from
dense granules upon stimulation and can synergistically prop-
agate aggregation and further dense granule secretion. When
platelets were co-stimulated with low concentrations of ago-
nists, thrombin (0.05–0.075 unit/ml) (Fig 4ci) or CRP-XL (0.3–
0.5g/ml) (Fig. 4C, ii) and 10MADP, the significant defect in
aggregation could be fully rescued in Stx8/ platelets (Fig.
4D). Dense granule secretion, however, remained significantly
reduced in Stx8/ platelets after thrombin-ADP co-stimula-
tion (Fig. 4e). CRP-ADP co-stimulation resulted in much
greater potentiation of secretion (200% comparedwith25%
increase in thrombin-stimulated platelets), masking any poten-
tial difference still present in Stx8/ (Fig. 4E).
STX8 Deletion Leads to Down-regulation of Another SNARE
VTI1B, Which, However, Is Not Involved in Secretion—To
ensure that the defects observedwere truly due to STX8 knock-
out, we analyzed expression levels of SNAREs and Munc/SEC
family members thought to be important in platelet secretion
(Fig. 5A). No difference in expression was found (Fig. 5B). We
did, however, find that levels of another primarily endosomal
SNARE, VTI1B, known to form complexes with STX8 in other
cells, were significantly reduced (the converse has also been
reported previously in Vti1b/ hepatocytes (27), and con-
firmed here, Fig. 5C).
The defect in dense granule secretion was not present in
Vti1b/, suggesting that this SNARE, despite being expressed
in platelets, was not involved in the same secretion events as
STX8 (Fig. 5, E–G). Similarly, dense granule secretion in
Stx8	/ platelets was not changed, further confirming that
complete ablation of STX8 is required for the defect to occur
(Fig. 5D).
Stx8/ Platelets Show Normal Thrombus Formation under
Flow in Vitro and in Vivo and Normal Tail Bleeding Times, but
Have Defective Thrombus Stability in Vivo—We observed
thrombus formation on two surfaces, collagen and fibrinogen,
under a shear stress of 1000 s1. We found that there was no
difference either in the rates of adhesion (Fig. 6, A and B) or in
FIGURE 5.Analysis of secretion inVti1b/platelets. A, expression levels of other known SNAREs and SNARE-associated proteins weremeasured in Stx8/
platelets to ensure the defect results from Stx8 deletion. Levels of STX11, VAMP8, SNAP23, and MUNC13d and 18b were comparable between the genotypes
(image representative of at least 3 independent experiments). B, a significant decrease in expression of Vti1b in Stx8/plateletswas observed (31.13 5.85%
ofWT expression, p 0.01).C, similarly, Stx8was also down-regulated in Vti1b/platelets.D, to confirm that only complete ablation of Stx8 leads to defective
densegranule secretion,weanalyzedATP secretion from Stx8	/platelets and foundnodefect, unlike in Stx8/platelets (n3, differencenot significant but
consistent for WT versus Stx8/, two-way ANOVA). E–G, to further confirm that deletion of Stx8 and not the associated down-regulation of Vti1b was
responsible for defect in dense granule secretion observed, wemeasured secretion from dense (E) and -granules (F) and lysosomes (G) in Vti1b/ platelets.
No difference was observed in any of the secretion events in Vti1b/ platelets (n 6). Error bars represent S.E.
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final coverage after 4 min of flow between Stx8/ and WT
platelets (Fig. 6C).
Similarly, both the average adhesion rate at the site of FeCl3
injury and the final size of thrombus were only slightly reduced
in Stx8/ animals, and the defects were not significant (Fig. 7,
A and B). Interestingly, however, when the videos were ana-
lyzed for numbers of embolization events (Fig. 7C and supple-
mental Videos S1 and S2) occurring during the experiment, we
found that thrombi formed in Stx8/ animals were less stable
and significantly more likely to embolize (Fig. 7D).
The finding that thrombus stability was altered in Stx8/
mice prompted assessment of their hemostatic potential. Tail
bleeding times were normal in Stx8/mice (Fig. 7E), suggest-
ing that Stx8 deletion despite affecting thrombosis, does not
lead to hemostatic abnormalities.
DISCUSSION
Although functional redundancy of mammalian (33), and
indeed platelet (16) SNAREs was demonstrated previously, the
one size fits all model remains generally accepted in platelets,
where the STX11-SNAP23-VAMP8complex is proposed as the
predominant SNARE complex regulating platelet secretion.
Until now, there was no other candidate Qbc SNARE(s) in
platelets apart fromSNAP23.However, the evidence in support
of SNAP23 remains incomplete. The initial studies suggesting
its role used the permeabilized platelet model, where Fab anti-
body fragments targeting SNAP23 were introduced into plate-
lets before stimulationwith calcium (17, 18, 34). Chen et al. and
Lemons et al. (17–19) found a significant, but not complete
ablation of all granule secretion using this assay. In the same
model, STX2 and -4 were shown to be important SNAREs for
all secretion events (17–19). Recently it was shown that the
antibodies used were in fact nonspecific and also blocked
STX11 (15), now known to be responsible for the secretion
defect in FHL-4. In light of the lack of other conclusive evi-
dence, investigating SNAREs that could “help” SNAP23 in reg-
ulating secretion was a promising direction.
In this study we show evidence for expression of the SNARE
STX8, previously unstudied in platelets.Our data suggest that it
could, possibly in complexes with “confirmed” SNARE STX11
and as yet unidentified Qb and R SNAREs, contribute to the
regulation of dense granule secretion.
STX8 was initially found in the endosomal SNARE complex
(14) but no functional data in any cell type on Stx8/ knock-
out mice is known to date. It was found to play a role in cystic
fibrosis transmembrane conductance regulator trafficking in
epithelial cells (35, 36), and Golgi-to-plasma membrane traf-
ficking of TrkA receptor in neurons (37) supporting its role in
endosomal trafficking. STX8 was, however, also found on the
plasma membrane of PC12 cells (38) suggesting that its di-leu-
cine-based motif may differentially function in both exocytotic
and endocytotic pathways. Recently, STX8 was also found to
localizewith lytic granules in cytotoxicT leukocytes, suggesting
a role in secretion in cells of hematopoietic lineage (39).
Platelet dense granules are lysosome-like organelles that
originate from multivesicular bodies in megakaryocytes (40)
and STX8has been implicated in endosome-to-lysosome trans-
FIGURE 6. Analysis of in vitro thrombus formation under shear in Stx8/ whole blood. Anti-coagulated whole blood was flowed over immobilized
collagen (50 g/ml) or fibrinogen (100 g/ml) through a parallel plate perfusion chamber at a shear rate of 1000 s1 for 4 min. A and B, the chamber was
constantly imaged over the time of experiment and the percentage coverage at each time point was acquired using QCapture software. The change in
coverage representsmean S.E. (n 4).C, at the end of each experiment, chamberswerewashed for 3minwith buffer to remove non-adherent platelets and
erythrocytes, and 30 random images of thewhole coverslip were taken. The surface area covered by thrombi was analyzed using ImageJ (n 4). Therewas no
difference in either the rate of adhesion or the size of thrombi in Stx8/, either on collagen (GPVI-mediated adhesion) or on fibrinogen (IIb3-mediated
adhesion). Error bars represent S.E.
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port, first in the NRK cell line (41), and also in macrophages
(42). It was possible that a STX8-containing SNARE complex is
involved in endosomal transport steps in megakaryocytes but
we found no apparent difference in platelet or granule mor-
phology. The 5-HT content of dense granules also appeared to
be equal. Therefore STX8 is unlikely to play a role in granule
formation.
Karim et al. (20) recently showed that the VAMP8-SNAP23-
STX11 complex associates following activation with thrombin.
In contrast, the novel STX8-STX11 interaction appeared to be
constitutive. If a pre-assembled complex was present in addi-
tion to an activation-dependent SNAP23-VAMP8-STX11
complex, it could indicate a subpopulation of dense granules
that could be released uponweaker stimulation.One possibility
would be the granules that are pre-docked to the target mem-
brane. We did not, however, find STX8 in complexes with
VAMP8 suggesting that either a different v-SNARE is involved,
or the lysis conditions did not preserve that interaction. Alter-
natively, the increased affinity of the complex could be due to
differences in accessory secretion regulators interacting with
the complex, such as the MUNC family, small GTPases or oth-
ers (43), but the role of many of those in platelets remains to be
elucidated.
The defect in dense granule secretion we observe under
stimulation with intermediate concentrations of agonists in
Stx8/ platelets could support this general model. A recent
study showed that release of distinct-granule cargomolecules
is kinetically heterogeneous and dependent on agonist (type,
rather than concentration) but no mechanistic data exists to
explain this (44). Dense granule secretion is even less well stud-
ied and is thought to occur very rapidly, but in view of the range
of functions that dense granule cargo small molecules play in
the vascular environment, it is likely that a level of spatial and
temporal regulation is required as well (45). STX8may contrib-
FIGURE 7. In vivo thrombus formation and embolization of analysis in Stx8/ andWT animals. Carotid artery damage was achieved by treatment with
FeCl3 as described. Fluorescently labeled platelets adhering at the site of injury could then be imaged continuously.A, the rate of platelet adhesionwas slower
in Stx8/, but the differencewas not significant (adhesion rate shownasmean S.E.). B, the final thrombi size (expressed as IFDof the field of view) at the end
of a 20-min experiment was also reduced in Stx8/ animals but the difference was not significant. The videos were then reviewed again, focusing on the
numberof embolizationevents as shown inC. Anembolus, seenhere as a small fragmentof the shell of thegrowing thrombus (arrowat 0 s) becomesdislodged
and initially “rolls” with the direction of blood flow (at 5 s) to eventually becomedetached from the thrombus and carried away by the blood flow (6 s).D,when
counted throughout the duration of the experiment, the number of embolization events was significantly increased in the Stx8/ (137.3 20.12) compared
withWT animals (75.46 17.71) (n 8, p 0.037, t test). E,mean time to cessation of bleeding in tail bleeding assay was the same in Stx8/ andWT animals
(t 180 s, n 6). Error bars represent S.E.
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ute to that regulation. STX11 is an unusual SNARE in that it
does not contain a traditional transmembrane domain (46). It is
thought that association with MUNC18b (47) together with
putative post-translational modifications (46) are required for
its membrane anchoring and stabilization, however, associa-
tion with a transmembrane syntaxin such as STX8 may also
contribute to this stabilization. This could lead to differential
complex dynamics and provide an additional mechanism for
dense granule secretion in response to low agonist stimulation.
Rather than any up-regulation, we observed a reduction in
the expression levels of VTI1B in Stx8/ platelets with the
expression of other known SNAREs and MUNCs not affected.
Lack of a comparable dense granule secretion defect in
Vti1b/platelets excludes it as an essential binding partner for
STX8 in this secretion event, despite previous reports of
VTI1B-STX8 pairing in membrane trafficking events in other
cell types (14, 27, 41, 42).
The defect in dense granule secretion and aggregation in
Stx8/ platelets did not translate to a defect in thrombus for-
mation in whole blood under shear. However, because we did
not see a defect in secretion at high levels of stimulation either
with thrombin or CRP, thismay suggest that the role of STX8 is
very specific to an intermediate level of stimulation. The level of
stimulation in the in vitro thrombus formation assay used
would activate positive feedback cascades and lead to an
increase in dense granule secretion that would most likely dis-
guise any defects in primary secretion.
Similarly, in the ferric chloride injury model, damage to the
vessel wall results in exposure of extracellular matrix far
exceeding the concentrations applied in an aggregation assay
and correspondingly, the total size of thrombus was only
slightly reduced in Stx8/ animals. However, importantly, it
was clear that Stx8/ thrombi embolized more readily, and
that the difference was significant. This could align with the
proposed “core and shell” structure to thrombi (48), because
the core consists of more activated, P-selectin expressing plate-
lets that would not be affected in the Stx8/ mice (because
P-selectin expression was normal in Stx8/). The “shell” con-
sists of “less” activated, loosely attached platelets and its stabil-
ity depends on P2Y12 signaling. Therefore the shell would be
more sensitive to changes in ADP signal intensity, such as is
present in the Stx8/ mouse where there is decreased dense
granule secretion. No difference in tail bleeding time between
genotypes further suggests that STX8 is more important in
thrombosis than in the hemostatic response.
The observation that STX8-mediated dense granule secre-
tion contributes to thrombus stability may have implications in
our search for selective anti-thrombotic agents that spare pri-
mary hemostasis (49). This analysis emphasizes that it is worth
considering alternative end points for analysis of in vivo gene
knock-out phenotypes presenting with less profound func-
tional defects in vitro. In the clinical setting, shedding of emboli
from the site of initial thrombus formation may give rise to
occlusive thrombus formation downstream in the vasculature
and lead to ischemic events. Whereas the effect of shear on
adhesion and aggregation in the vasculature was recently
reviewed elsewhere (50), the secretion underlying thrombus
stabilization under flow remains to be elucidated.
In summary, we have shown that a novel SNARE protein,
interacting with the previously reported important SNARE
STX11 contributes selectively to dense granule secretion. This
translates into a relevant increase in thrombus stability in vivo.
Further studies are needed to understand the importance of
this in the full range of physiological and pathological processes
mediated by platelet dense granule secretion.
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